| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/14/2013 | US20130064887 Pharmaceutical compositions |
| 03/14/2013 | US20130064886 Microtablets for Drug Delivery |
| 03/14/2013 | US20130064885 Probiotic products for pet applications |
| 03/14/2013 | US20130064884 Composition and method for treating ketosis in cows |
| 03/14/2013 | US20130064883 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 03/14/2013 | US20130064882 Compositions and Methods for the Prevention of Cancer in High Risk Patients |
| 03/14/2013 | US20130064881 Compositions and methods for treating prostate cancer |
| 03/14/2013 | US20130064880 Administration regime for n-hydroxy-4-benzamide |
| 03/14/2013 | US20130064879 Compositions and Methods for Inhibiting Viral Replication |
| 03/14/2013 | US20130064878 Wound healing compositions and methods |
| 03/14/2013 | US20130064877 Composition for the transdermal delivery of fentanyl |
| 03/14/2013 | US20130064876 Process of treatment of fibers and/or textile materials |
| 03/14/2013 | US20130064875 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/14/2013 | US20130064874 Method for producing orally administrable edible agent of aggregated substance-containing laminate film form and orally administrable edible agent of aggregated substance-containing laminate film form |
| 03/14/2013 | US20130064870 Dry powder inhalation composition |
| 03/14/2013 | US20130064869 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/14/2013 | US20130064868 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/14/2013 | US20130064867 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine |
| 03/14/2013 | US20130064866 Pulmonary and nasal delivery of serum amyloid p |
| 03/14/2013 | US20130064865 Therapy to reduce extravasation damage |
| 03/14/2013 | US20130064864 Submicron particles to decrease transfusion |
| 03/14/2013 | US20130064863 Multicomponent and biocompatible nanocomposite materials, methods of synthesizing same and applications of same |
| 03/14/2013 | US20130064862 Systems and methods for shell encapsulation |
| 03/14/2013 | US20130064861 Compositions and methods for modifying in vivo calcification of hydrogels |
| 03/14/2013 | US20130064860 Combination pharmaceutical composition and methods of theating genitourinary system disorders |
| 03/14/2013 | US20130064778 Oral hygiene products and method |
| 03/14/2013 | US20130064777 Surfactant-free water-free foamable compositions, breakable foams and gels their uses |
| 03/14/2013 | US20130064774 Methods and compositions for maintenance of a functional wound |
| 03/14/2013 | US20130064759 Copolymer-stabilized emulsions |
| 03/14/2013 | DE102011112898A1 Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen Nanoparticulate phosphate adsorbent based on maghemite or maghemite / magnetite, its preparation and uses |
| 03/14/2013 | CA2849448A1 Oral delivery for hemoglobin based oxygen carriers |
| 03/14/2013 | CA2849423A1 Silicone coated implants |
| 03/14/2013 | CA2848359A1 Cellular uptake control systems |
| 03/14/2013 | CA2848163A1 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine |
| 03/14/2013 | CA2848142A1 Hydrogels with biodegradable crosslinking |
| 03/14/2013 | CA2848026A1 Hyaluronic acid/collagen- based dermal filler compositions and methods for making same |
| 03/14/2013 | CA2848006A1 Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof |
| 03/14/2013 | CA2847817A1 Treating cough and tussive attacks |
| 03/14/2013 | CA2847555A1 Materials and methods for modulating immune responses |
| 03/14/2013 | CA2847114A1 Method for manufacturing block copolymer |
| 03/14/2013 | CA2846884A1 Pharmaceutical compositions comprising an aromatase inhibitor |
| 03/14/2013 | CA2846676A1 Targeted liposomes in cancer therapy |
| 03/14/2013 | CA2846299A1 Oral suspension |
| 03/14/2013 | CA2845929A1 Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases |
| 03/14/2013 | CA2838289A1 Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
| 03/13/2013 | EP2567952A1 Cationic lipid |
| 03/13/2013 | EP2567710A1 Aqueous pharmaceutical system for the administration of drugs to the nails |
| 03/13/2013 | EP2567702A1 A particulate system comprising lanthanides for use in diminishing cell growth/inducing cell killing |
| 03/13/2013 | EP2567700A1 Vitamin-containing nutrition infusion for administration through peripheral vein |
| 03/13/2013 | EP2567693A1 Lipid encapsulated interfering RNA |
| 03/13/2013 | EP2567692A1 Use of a device for obtaining interleukin-1 receptor antagonist rich solutions |
| 03/13/2013 | EP2567691A1 Aqueous compositions comprising arbekacin |
| 03/13/2013 | EP2567690A1 The use of amisulpride as an anti-emetic |
| 03/13/2013 | EP2567689A1 Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
| 03/13/2013 | EP2567618A1 Pharmaceutical composition containing an N-phenylpyrazole derivative, use for the preparation of a topical veterinary drug for flea control |
| 03/13/2013 | EP2566878A1 Methods of inhibiting inflammation and inflammatory diseases using gal-3bp (btbd17b, lgals3bp, galectin-3 binding protein, mac-2 binding protein) |
| 03/13/2013 | EP2566535A2 Releasing device for administering a bio-active agent |
| 03/13/2013 | EP2566522A1 Imageable activatable agent for radiation therapy and method and system for radiation therapy |
| 03/13/2013 | EP2566521A2 Immunogen adherence and method of making and using same |
| 03/13/2013 | EP2566501A2 Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
| 03/13/2013 | EP2566488A2 Povidone-iodine topical composition |
| 03/13/2013 | EP2566487A1 Ophthalmic composition |
| 03/13/2013 | EP2566485A1 Immunostimulatory compositions and methods of use thereof |
| 03/13/2013 | EP2566474A2 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
| 03/13/2013 | EP2566472A1 A pharmaceutical composition comprising aspirin and bisoprolol |
| 03/13/2013 | EP2566468A2 Drug delivery coating and devices |
| 03/13/2013 | EP2566467A1 Mucosal film containing two sugar substitutes |
| 03/13/2013 | EP2566466A1 Micropellet compositions comprising pancreatin containing digestive enzyme mixtures |
| 03/13/2013 | EP2566465A2 Stable rosuvastatin formulations |
| 03/13/2013 | EP2566464A1 Pharmaceutical formulations comprising pioglitazone and linagliptin |
| 03/13/2013 | EP2566463A1 Extended release thiocolchicoside tablets |
| 03/13/2013 | EP2566462A1 Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
| 03/13/2013 | EP2566461A2 Solid tapentadol in non-crystalline form |
| 03/13/2013 | EP2566460A1 Compositions and methods for enhancing physiological performance and recovery time |
| 03/13/2013 | EP2566459A1 Methods devices and systems of preparing targeted microbubble shells |
| 03/13/2013 | EP2566458A2 Pharmaceutical formulations compising cefuroxime axetil |
| 03/13/2013 | EP2566457A1 Topical pharmaceutical composition comprising heparin |
| 03/13/2013 | EP2566456A2 Triamcinolone acetonide formulations for treating dermatitis and psoriasis |
| 03/13/2013 | EP2566455A1 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies |
| 03/13/2013 | EP2566454A1 Chitosan composition |
| 03/13/2013 | EP2566453A1 Novel ophthalmic compositions |
| 03/13/2013 | EP2566452A1 Melting tablet comprising a triptane or atypical neuroleptic |
| 03/13/2013 | EP2566451A1 Pharmaceutical compositions comprising cefditoren pivoxil |
| 03/13/2013 | EP2566450A2 Pharmaceutical compositions comprising cefetamet |
| 03/13/2013 | EP2566449A2 Pharmaceutical compositions comprising ceftibuten |
| 03/13/2013 | EP2566448A2 Efervescent formulations comprising cefdinir |
| 03/13/2013 | EP2566447A2 Stabilized ophthalmic galactomannan formulations |
| 03/13/2013 | EP2566446A2 Novel low concentration meloxicam tablets |
| 03/13/2013 | EP2566335A1 Controlled release from macromolecular conjugates |
| 03/13/2013 | EP2566331A1 Pharmaceutical compositions and methods of making same |
| 03/13/2013 | EP2566325A1 Compositions of small molecule therapeutics |
| 03/13/2013 | EP2407536A9 ADP-ribosyl transferase fusion variant proteins |
| 03/13/2013 | CN202777136U Medicine plaster |
| 03/13/2013 | CN202777135U Anti-seepage ventilate traditional Chinese medicine patch |
| 03/13/2013 | CN202777134U Novel beautifying capsule |
| 03/13/2013 | CN202777133U Aspirin enteric controlled-release preparation |
| 03/13/2013 | CN202777132U Oral administration buccal tablet for treating throat inflammation |
| 03/13/2013 | CN202777131U Suppository for supplementing potassium for anus |
| 03/13/2013 | CN102971327A Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same |
| 03/13/2013 | CN102971069A Melt emulsification |